Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

How to Tune Out Market Noisefool.com
Via The Motley Fool · March 28, 2025
Why Shares of GE Aerospace Are Down Today Despite a Lift From Wall Streetfool.com
Via The Motley Fool · March 28, 2025
Why Digital Ad Giants Alphabet, Meta Platforms, and Netflix Plunged Todayfool.com
Via The Motley Fool · March 28, 2025
Top 3 Dividend Champions Among The Worst Performers In 2025talkmarkets.com
The S&P 500 Index is off to a challenged start to the year. Many dividend stocks are off to much worse starts year-to-date, which could present value and income investors with some compelling buying opportunities.
Via Talk Markets · March 28, 2025
The Table Is Set for Q2: Are You Ready?talkmarkets.com
Does the U.S. market matter more than most?
Via Talk Markets · March 28, 2025
TSMC Stock Under Pressure From Tariff Concerns, But Analysts Stay Bullishtalkmarkets.com
Via Talk Markets · March 28, 2025
Eurozone Sentiment Weakens Ahead Of Steeper Tariffstalkmarkets.com
Weakening service sector activity and deteriorating consumer confidence have prompted a drop in sentiment across the eurozone.
Via Talk Markets · March 28, 2025
Curious about the most active S&P500 stocks in today's session?chartmill.com
Let's have a look at what is happening on the US markets on Friday. Below you can find the most active S&P500 stocks in today's session.
Via Chartmill · March 28, 2025
U.S. Auto Stocks Suffer As Tariffs Threaten ‘Irreparable Damage’talkmarkets.com
Announcing the tariffs in the Oval Office on Thursday, Trump argued that the new measures would create “tremendous growth” in the United States.
Via Talk Markets · March 28, 2025
Where Digital Realty Trust Stands With Analystsbenzinga.com
Via Benzinga · March 28, 2025
What Does the Market Think About Pfizer?benzinga.com
Via Benzinga · March 28, 2025
A Look Into Taiwan Semiconductor Inc's Price Over Earningsbenzinga.com
Via Benzinga · March 28, 2025
Is the Market Bullish or Bearish on PDD Holdings?benzinga.com
Via Benzinga · March 28, 2025
How Is The Market Feeling About West Pharmaceutical Servs?benzinga.com
Via Benzinga · March 28, 2025
Here's How Much You Would Have Made Owning Ecolab Stock In The Last 20 Yearsbenzinga.com
Via Benzinga · March 28, 2025
Friday's session: most active stockschartmill.com
Curious about the most active stocks on Friday? Find out which stocks are dominating the market action!
Via Chartmill · March 28, 2025
3 Dividend Giants To Buy As Tariffs Hit Stocksbenzinga.com
Via Benzinga · March 28, 2025
Why Chainlink, Avalanche, and Mara Holdings Jumped (and Then Dropped) This Weekfool.com
Via The Motley Fool · March 28, 2025
Big Moves At Intel: These 3 ETFs Stand To Benefitbenzinga.com
Intel Corporation (NASDAQ: INTC) is undergoing strategic shifts under new CEO Lip-Bu Tan, making ETFs with significant Intel holdings a potential investment opportunity.
Via Benzinga · March 28, 2025
Donald Trump Pardons BitMex Co-Founders Arthur Hayes, Benjamin Delo, Samuel Reedbenzinga.com
President Donald Trump has pardoned the three co-founders of cryptocurrency exchange BitMEX, who previously pled guilty to federal charges related to money laundering and regulatory violations.
Via Benzinga · March 28, 2025
'My Spidey Tingles' — Gold's Surge Has Some Investors On Edgebenzinga.com
The anchor underpinning trust in the U.S. monetary system, that is the confidence in the Federal Reserve's ability to keep consumer price changes on track, is facing its most severe test in decades, as inflation expectations spiral.
Via Benzinga · March 28, 2025
Battle At The 200 DMA, WGO Earningstalkmarkets.com
The S&P reclaimed its 200 DMA on Monday after comments from the Trump Administration over the weekend about reducing the scope of tariffs.
Via Talk Markets · March 28, 2025
Options Corner: Coinbase's Crossroads — Bearish Signal Or Bullish Opportunity?benzinga.com
Although Coinbase's imminent death cross seemingly spells trouble, the signal could be a contrarian one for COIN stock.
Via Benzinga · March 28, 2025
European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogenbenzinga.com
Eli Lilly's donanemab faces a setback as EMA's CHMP issues a negative opinion. Analysts expect Lilly to appeal, citing past reversals in similar cases.
Via Benzinga · March 28, 2025
FDA OKs Novartis Prostate Cancer Treatment, Triples Eligible Patient Poolbenzinga.com
FDA approves Novartis' Pluvicto for advanced prostate cancer patients who have received ARPI therapy.
Via Benzinga · March 28, 2025